Coldstream Capital Management Inc Fennec Pharmaceuticals Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 625 shares of FENC stock, worth $3,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
625Holding current value
$3,881% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FENC
# of Institutions
72Shares Held
14.1MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$25.3 Million0.71% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$14.9 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$14 Million11.1% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$7.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA965KShares$5.99 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $162M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...